Show simple item record

dc.contributor.authorLim, Wai H
dc.contributor.authorAdams, Brigitte
dc.contributor.authorAlexander, Stephen
dc.contributor.authorBouts, Antonia HM
dc.contributor.authorClaas, Frans
dc.contributor.authorCollins, Michael
dc.contributor.authorCornelissen, Elisabeth
dc.contributor.authorDunckley, Heather
dc.contributor.authorde Jong, Huib
dc.contributor.authorD'Orsogna, Lloyd
dc.contributor.authorFrancis, Anna
dc.contributor.authorHeidt, Sebastiaan
dc.contributor.authorHerman, Jean
dc.contributor.authorHoldsworth, Rhonda
dc.contributor.authorKausman, Joshua
dc.contributor.authorKhalid, Rabia
dc.contributor.authorKim, Jon Jin
dc.contributor.authorKim, Siah
dc.contributor.authorKnops, Noël
dc.contributor.authorKosmoliaptsis, Vasilis
dc.contributor.authorKramer, Cynthia
dc.contributor.authorKuypers, Dirk
dc.contributor.authorLarkins, Nicholas
dc.contributor.authorPalmer, Suetonia C
dc.contributor.authorPrestidge, Chanel
dc.contributor.authorPrytula, Agnieszka
dc.contributor.authorSharma, Ankit
dc.contributor.authorShingde, Meena
dc.contributor.authorTaverniti, Anne
dc.contributor.authorTeixeira-Pinto, Armando
dc.contributor.authorTrnka, Peter
dc.contributor.authorWillis, Francis
dc.contributor.authorWong, Daniel
dc.contributor.authorWong, Germaine
dc.date.accessioned2022-01-05T16:28:44Z
dc.date.available2022-01-05T16:28:44Z
dc.date.issued2021-12-19
dc.date.submitted2021-09-22
dc.identifier.issn1471-2369
dc.identifier.others12882-021-02619-0
dc.identifier.other2619
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/332040
dc.description.abstractBACKGROUND: Parental donor kidney transplantation is the most common treatment option for children and adolescents with kidney failure. Emerging data from observational studies have reported improved short- and medium-term allograft outcomes in recipients of paternal compared to maternal donors. The INCEPTION study aims to identify potential differences in immunological compatibility between maternal and paternal donor kidneys and ascertain how this affects kidney allograft outcomes in children and adolescents with kidney failure. METHODS: This longitudinal observational study will recruit kidney transplant recipients aged ≤18 years who have received a parental donor kidney transplant across 4 countries (Australia, New Zealand, United Kingdom and the Netherlands) between 1990 and 2020. High resolution human leukocyte antigen (HLA) typing of both recipients and corresponding parental donors will be undertaken, to provide an in-depth assessment of immunological compatibility. The primary outcome is a composite of de novo donor-specific anti-HLA antibody (DSA), biopsy-proven acute rejection or allograft loss up to 60-months post-transplantation. Secondary outcomes are de novo DSA, biopsy-proven acute rejection, acute or chronic antibody mediated rejection or Chronic Allograft Damage Index (CADI) score of > 1 on allograft biopsy post-transplant, allograft function, proteinuria and allograft loss. Using principal component analysis and Cox proportional hazards regression modelling, we will determine the associations between defined sets of immunological and clinical parameters that may identify risk stratification for the primary and secondary outcome measures among young people accepting a parental donor kidney for transplantation. This study design will allow us to specifically investigate the relative importance of accepting a maternal compared to paternal donor, for families deciding on the best option for donation. DISCUSSION: The INCEPTION study findings will explore potentially differential immunological risks of maternal and paternal donor kidneys for transplantation among children and adolescents. Our study will provide the evidence base underpinning the selection of parental donor in order to achieve the best projected long-term kidney transplant and overall health outcomes for children and adolescents, a recognized vulnerable population. TRIAL REGISTRATION: The INCEPTION study has been registered with the Australian New Zealand Clinical Trials Registry, with the trial registration number of ACTRN12620000911998 (14th September 2020).
dc.languageen
dc.publisherSpringer Science and Business Media LLC
dc.subjectStudy Protocol
dc.subjectKidney transplant
dc.subjectChildren
dc.subjectAdolescents
dc.subjectParental donor
dc.subjectImmunological profile
dc.subjectHuman leukocyte antigen
dc.subjectAntibody
dc.subjectRejection
dc.subjectAllograft loss
dc.titleImprove in-depth immunological risk assessment to optimize genetic-compatibility and clinical outcomes in child and adolescent recipients of parental donor kidney transplants: protocol for the INCEPTION study.
dc.typeArticle
dc.date.updated2022-01-05T16:28:43Z
prism.issueIdentifier1
prism.publicationNameBMC Nephrol
prism.volume22
dc.identifier.doi10.17863/CAM.79487
dcterms.dateAccepted2021-11-23
rioxxterms.versionofrecord10.1186/s12882-021-02619-0
rioxxterms.versionVoR
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by/4.0/
dc.contributor.orcidLim, Wai H [0000-0002-3410-3572]
dc.contributor.orcidKosmoliaptsis, Vasilis [0000-0001-7298-1387]
dc.identifier.eissn1471-2369
cam.issuedOnline2021-12-19


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record